The primary goal of the Developmental Core of the Harvard University CFAR is to promote basic, clinical, behavioral and translational HIV/AIDS research activities at Harvard University. The Developmental Core provides the infrastructure through which short-term research proposals from individual and collaborating investigators are solicited, reviewed, and funded. The Developmental Core also promotes HIV research collaboration across Harvard University, and facilitates the development of new experimental approaches in high priority areas. Through funding of Scholar awards and prioritizing funding of investigators without prior R01-type funding, the Developmental Core fosters career development of junior HIV researchers. Dr. Johnson will serve as the Director of the Developmental Core, working in concert with the Associate Director, Dr. Shahin Lockman (HSPH, BWH) and the HU CFAR Administrative Staff.
The overarching goal of the Developmental Core is to further the research priorities of the HU CFAR as outlined by the research agendas of the Scientific Programs by helping to develop and promote multidisciplinary research in the prevention, detection, and treatment of HIV/AIDS in areas of basic, clinical, epidemiological, behavioral, and translational research.
|Hyle, Emily P; Mayosi, Bongani M; Middelkoop, Keren et al. (2017) The association between HIV and atherosclerotic cardiovascular disease in sub-Saharan Africa: a systematic review. BMC Public Health 17:954|
|Luckow, Peter W; Kenny, Avi; White, Emily et al. (2017) Implementation research on community health workers' provision of maternal and child health services in rural Liberia. Bull World Health Organ 95:113-120|
|McCluskey, Suzanne M; Boum 2nd, Yap; Musinguzi, Nicholas et al. (2017) Brief Report: Appraising Viral Load Thresholds and Adherence Support Recommendations in the World Health Organization Guidelines for Detection and Management of Virologic Failure. J Acquir Immune Defic Syndr 76:183-187|
|Viganò, Selena; Negrón, Jordi J; Tse, Samantha et al. (2017) HLA-G+ HIV-1-specific CD8+ T cells are associated with HIV-1 immune control. AIDS 31:207-212|
|Brown, Danielle N; Langan, Sinéad M; Freeman, Esther E (2017) Task Shifting in Dermatology: A Call to Action. JAMA Dermatol 153:1179-1180|
|Calabrese, Sarah K; Underhill, Kristen; Mayer, Kenneth H (2017) HIV Preexposure Prophylaxis and Condomless Sex: Disentangling Personal Values From Public Health Priorities. Am J Public Health 107:1572-1576|
|Janjua, Sumbal A; Staziaki, Pedro V; Szilveszter, Balint et al. (2017) Presence, Characteristics, and Prognostic Associations of Carotid Plaque Among People Living With HIV. Circ Cardiovasc Imaging 10:|
|Manickam, Cordelia; Martinot, Amanda J; Jones, Rhianna A et al. (2017) Hepatic immunopathology during occult hepacivirus re-infection. Virology 512:48-55|
|Levison, Julie H; Bogart, Laura M; Khan, Iman F et al. (2017) ""Where It Falls Apart"": Barriers to Retention in HIV Care in Latino Immigrants and Migrants. AIDS Patient Care STDS 31:394-405|
|Mayer, Kenneth H; Jones, Daniel; Oldenburg, Catherine et al. (2017) Optimal HIV Postexposure Prophylaxis Regimen Completion With Single Tablet Daily Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine Compared With More Frequent Dosing Regimens. J Acquir Immune Defic Syndr 75:535-539|
Showing the most recent 10 out of 944 publications